With the drug discovery timeline exceptionally long and
late-stage failure rates very high, there is tremendous pressure
to reduce the discovery timeframe and bring effective
therapies to market sooner. How investigators approach
studies that use lab animal models can directly impact those
goals. Kenneth Albrecht, Ph.D., Scientific Program Manager
at Taconic Biosciences, looks into the creative approaches
to rodent model generation and breeding, and how they can
significantly reduce the associated timeline while ensuring
the timely availability of the high-quality models upon which
drug discovery depends.

Comments are closed.

%d bloggers like this: